Abbott (ABT) Stock Rated Buy on Strong Diabetes Trial Results.
Share this article
Earnings
Score 65
Bullish
Abbott (ABT) Stock Rated Buy on Strong Diabetes Trial Results
Mar 24, 2026 11:27 UTC
ABT, XLV, JNJ
Medium term
Related Articles
Score 65
Bullish
Resilience of Travel Boosted Hilton Worldwide Holdings (HLT) in Q4
Mar 24, 13:40
Score 65
Bullish
Cardinal Health (CAH) Surged Following Improved Specialty Mix in Pharma
Mar 24, 13:37
Score 45
Bullish
Brown Advisory Mid-Cap Growth Strategy Bets on Medline (MDLN) in IPO
Mar 24, 13:34
Score 45
Everpure (PSTG) was Volatile Despite Strong Results
Mar 24, 13:27
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.